Updates on medical advances, environmental initiatives, and emerging technologies.
Technion researchers have developed materials that greatly boost MRI sensitivity, enabling earlier disease detection and reducing reliance on radiation-heavy scans like PET-CT.
A Technion research team has created an AI system that analyses digital biopsy scans to detect PD-L1 protein expression in breast cancer patients. This aids in tailoring immunotherapy treatments and addresses the global shortage of pathologists.
Israeli startup H2Pro, utilising technology from the Technion, has signed a strategic agreement with Moroccan renewable energy developer Gaia Energy to supply green hydrogen. This partnership aims to harness renewable resources for sustainable energy solutions.
Technion researchers have developed CarGrow, a red algae-based microgel that prevents shrinkage in 3D-printed tissues for transplantation. Its transparent structure allows real-time monitoring of tissue growth, improving the reliability of bioprinted transplants.
Technion researchers have developed an antibiotic cocktail that effectively prevents resistance in Staphylococcus aureus, a major cause of hospital-acquired infections. This innovative approach could enhance long-term treatment efficacy and combat the rise of superbugs.
Technion scientists have created a device that extracts clean drinking water from humidity—providing a potential game-changer for drought-prone and arid communities.
